Cero Therapeutics Holdings CERO
OTC CERO
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings, Inc. (CERO) Notes Payables (2022 - 2026)

Updated

Cero Therapeutics Holdings (CERO) reported Notes Payables of $746,647 for Q2 2026.

Analysis

Cero Therapeutics Holdings, Inc. (CERO) Notes Payables (2022 - 2026) Analysis & Trends

At the end of FY2023, Cero Therapeutics Holdings posted Notes Payables of $599,692, down 7.7% from FY2022.

  • By year, Notes Payables came in at $650,000 in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Notes Payables since Q3 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 746,647.00
Sep 30, 2024 102,274.00
Jun 30, 2024 253,174.00
Mar 31, 2024 402,514.00
Dec 31, 2023 599,692.00
Sep 30, 2023 1.40 Mn
Jun 30, 2023 1.18 Mn
Mar 31, 2023 650,000.00
Dec 31, 2022 650,000.00
API Access

Cero Therapeutics Holdings, Inc. Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=CERO&period=max&api_key=YOUR_API_KEY